DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.48) by 35.81 percent. This is a 60.42 percent increase over losses of $(2.40) per share from the same period last year. The company reported quarterly sales of $5.584 million which beat the analyst consensus estimate of $5.484 million by 1.81 percent. This is a 17.30 percent decrease over sales of $6.752 million the same period last year.